Landscapes / Targets
EZH2
9 drugs act on EZH2, in 30 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs9
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 13 Feb 2027Phase 3 trial completes | |||
| Next date | 13 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma and 1 more | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Phase 3 | Dec 2026Phase 1/2 trial completes | ||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Prostate Cancer, Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Relapsed/Refractory Peripheral T Cell Lymphoma, Metastatic Castrate-Resistant Prostate Cancer and 8 more | ||||
| Open drug page | |||||
— |
Pfizer · Public PFE |
Phase 3 | 28 Feb 2027Phase 3 trial completes | ||
| Next date | 28 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC) and 7 more | ||||
| Open drug page | |||||
— |
Phase 3 | 1 May 2028Phase 2 trial completes | |||
| Next date | 1 May 2028 · Phase 2 trial completes | ||||
| Also tested for | PTCL, NK T-Cell Lymphoma and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | FL Lymphoma, Epithelioid Sarcoma and 3 more | ||||
| Open drug page | |||||
Valemetostat tosylatenot checked |
— |
Phase 2 | 30 Mar 2028Phase 1/2 trial completes | ||
| Next date | 30 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma, Malignant, Non-hodgkin Lymphoma and 6 more | ||||
| Open drug page | |||||
— |
Novartis · Public NVS |
Phase 1/2 | 9 Nov 2029Phase 1/2 trial completes | ||
| Next date | 9 Nov 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Diffuse Large B Cell Lymphoma and 8 more | ||||
| Open drug page | |||||
— |
Hanmi · Public 128940.KS |
Phase 1 | Jan 2028Phase 1 trial completes | ||
| Next date | Jan 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 8 of 9 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026